Funds and ETFs Stryker Corporation

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 18:31:00 15/05/2024 BST 5-day change 1st Jan Change
331.3 USD +2.17% Intraday chart for Stryker Corporation +0.76% +10.79%

ETFs positioned on Stryker Corporation

Name Weight AuM 1st Jan change Investor Rating
0.08% 2 M€ +3.16% -
0.07% 1,006 M€ -.--% -
0.07% 414 M€ +11.73% -
0.07% 26 M€ +16.85% -
0.07% 9 M€ +9.94% -
0.07% 756 M€ +1.31% -
0.07% 17 M€ +4.92% -
0.07% 29 M€ -.--% -
0.07% 322 M€ +13.88% -
0.06% 105 M€ +4.05% -
0.06% 6 M€ +3.89%
0.05% 169 M€ +0.58% -
0.05% 32 M€ +1.38% -
0.05% 17 M€ +2.74% -
0.04% 15 M€ -1.62% -
0.03% 54 M€ +1.07% -
0.03% 6 M€ -4.26% -
0.02% 8 M€ +0.48% -
0.02% 112 M€ +5.62% -
0.01% 3 M€ +6.30% -
0.00% 11 M€ +2.55% -
16.27% 254 M€ +9.73% -
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
324.3 USD
Average target price
372.4 USD
Spread / Average Target
+14.82%
Consensus
  1. Stock Market
  2. Equities
  3. SYK Stock
  4. Funds and ETFs Stryker Corporation